Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

USP34

ubiquitin specific peptidase 34

translation score 0.59, read 2026-10-17; 1 sealed predictions, 0 held; 1 receipts.

Six readers

readerfoundscore
genetics
Open Targets
genetic association 0.46 (overall 0.28)0.46
cell type
Human Protein Atlas
expressed broadly, no clear home in brain cells0.40
chemistry
Open Targets
a small-molecule pocket0.60
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
1 Parkinson's papers of 760.91
pathways
Reactome
2 pathways; mostly other0.30
proposal for USP34, translation score 0.59

Knock down and overexpress USP34 in a dopamine neuron, astrocyte and microglia tri-culture; measure a transcriptome-wide state shift (bulk RNA-seq) and dopamine neuron survival after α-synuclein fibril challenge.

Cell type
a dopamine neuron, astrocyte and microglia tri-culture
Direction
Both arms: public data does not say which way helps.
Molecular readout
a transcriptome-wide state shift (bulk RNA-seq)
Functional readout
dopamine neuron survival after α-synuclein fibril challenge
Rule-out
If neither arm moves a transcriptome-wide state shift (bulk RNA-seq) by 20% or more against non-targeting and empty-vector controls, across three independent differentiations, the hypothesis is wrong.
Lab request
CRISPRi knockdown and lentiviral overexpression of USP34 in a tri-culture of iPSC dopamine neurons, astrocytes and microglia; n = 3 differentiations; readouts: a transcriptome-wide state shift (bulk RNA-seq); dopamine neuron survival after α-synuclein fibril challenge. Controls: non-targeting guide, empty vector. About 8 to 10 weeks, most of it differentiation.

Sealed predictions

  1. USP34 in dopamine neurons, braak+0.40 (p 0.291) → -0.16 (p 0.689)receipt 1418

Swarm cases

receipt 1418: USP34 in dopamine neurons, braak

power
full sample +0.20 (p 0.434, n 18), 95% CI -0.30 to +0.61. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.20 (p 0.424, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.34 (p 0.167, n 18). could be the mix.
skeptic
leave-one-out range +0.10 to +0.35, sign flips 0; without severely affected donors +0.20 (p 0.434, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for USP34 in dopamine neurons.

case closed: nothing better to follow up.

Receipts

loading the receipts